Carol Farver

45.0k total citations · 1 hit paper
179 papers, 5.9k citations indexed

About

Carol Farver is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Carol Farver has authored 179 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Pulmonary and Respiratory Medicine, 62 papers in Surgery and 31 papers in Physiology. Recurrent topics in Carol Farver's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers), Transplantation: Methods and Outcomes (37 papers) and Medical Imaging and Pathology Studies (23 papers). Carol Farver is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers), Transplantation: Methods and Outcomes (37 papers) and Medical Imaging and Pathology Studies (23 papers). Carol Farver collaborates with scholars based in United States, Egypt and United Kingdom. Carol Farver's co-authors include Suzy Comhair, Serpil C. Erzurum, Mani S. Kavuru, Mary Jane Thomassen, Raed A. Dweik, James K. Stoller, Richard A. Prayson, Erik Thunnissen, Sarah E. Gibson and Anagha Malur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Carol Farver

175 papers receiving 5.8k citations

Hit Papers

Banff 2011 Meeting Report: New Concepts in Antibody-Media... 2012 2026 2016 2021 2012 100 200 300

Peers

Carol Farver
Comparison fields: 5 of 155
  • Pulmonary and Respiratory Medicine 2.4k
  • Surgery 1.3k
  • Molecular Biology 1.2k
  • Physiology 1.0k
  • Oncology 776
Replace Michael S. Mulligan with:
Michael S. Mulligan United States
Sandra M. Herrmann United States
Paul C. Kuo United States
Gerhard A. Müller Germany
Pierre Ronco France
Flora Peyvandi Italy
Larry R. Kaiser United States
Mauro Gacci Italy
Giuseppe Lucarelli Italy
A. Michael Peters United Kingdom
Michael S. Mulligan United States View profile →
Citations per field, relative to Carol Farver
Carol Farver · 1×
Citations per year, relative to Carol Farver
Carol Farver · 1×

Countries citing papers authored by Carol Farver

Since Specialization
Citations

This map shows the geographic impact of Carol Farver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Farver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Farver more than expected).

Fields of papers citing papers by Carol Farver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Farver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Farver. The network helps show where Carol Farver may publish in the future.

Co-authorship network of co-authors of Carol Farver

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Farver. A scholar is included among the top collaborators of Carol Farver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Farver. Carol Farver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 8
3 0
4 9
5 20
6 26
7 44
8 14
9 6
10 29
11 20
12
Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection breakdown →
316
13 130
14
Neoplastic lung disease
1
15
Nonneoplastic lung disease
11
16 80
17
Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
30
18
Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.
103
19 56
20 239

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026